δ-acetylornithine | 13215-18-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: δ-acetylornithine
• 英文别名: N-delta-acetylornithine；δ-Acetylornithin；δ-N-Acetylornithin；Nδ-Acetyl-ornithin；N^δ-acetyl-DL-ornithine；N^δ-Acetyl-DL-ornithin；DL-2-Amino-5-acetamino-valeriansaeure；5-Acetamido-2-azaniumylpentanoate；5-acetamido-2-azaniumylpentanoate
• CAS: 13215-18-4
• 化学式: C₇H₁₄N₂O₃
• 分子量: 174.2
• InChiKey: SRXKAYJJGAAOBP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.7
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  92.4
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  乙酸酐 、 alkaline earth salt of/the/ methylsulfuric acid 在 barium dihydroxide 、 水 作用下， 生成 δ-acetylornithine
  参考文献：
  名称：

  Neuberger; Sanger, Biochemical Journal, 1944, vol. 38, p. 125,127

  摘要：

  DOI：

文献信息

• [EN] BETA-HAIRPIN PEPTIDOMIMETICS<br/>[FR] PEPTIDOMIMÉTIQUES EN ÉPINGLE À CHEVEUX BÊTA
  申请人：POLYPHOR AG

  公开号：WO2016150576A1

  公开（公告）日：2016-09-29

  Beta-hairpin peptidomimetics of the general formula (I), and pharmaceutically acceptable salts thereof, with P, T, Q., and optionally L being elements as defined in the description and the claims, have Gram-negative antimicrobial activity to e.g. inhibit the growth or to kill microorganisms such as Klebsiellapneumoniae and/or Acinetobacter baumannii and/or Escherichia coli and/or Pseudomonas aeruginosa. They ca n be used as medicaments to treat or prevent infections or as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.

  Beta-发夹仿生肽的一般公式（I），及其药学上可接受的盐，其中P、T、Q.，以及可选的L作为描述和权利要求中定义的元素，具有抗革兰氏阴性微生物活性，例如抑制生长或杀灭肺炎克雷伯菌、包括鲍曼不动杆菌、大肠杆菌和铜绿假单胞菌等微生物。它们可用作药物治疗或预防感染，或用作食品、化妆品、药物或其他含营养物质的材料的消毒剂。这些仿生肽可以通过基于混合固相和溶液相合成策略的过程制造。
• BETA-HAIRPIN PEPTIDOMIMETICS
  申请人：POLYPHOR AG

  公开号：US20160052971A1

  公开（公告）日：2016-02-25

  Beta-hairpin peptidomimetics of the general formula (I), cyclo[P 1 -p 2 -p 3 -p 4 -p 5 -p 6 -p 7 -p 8 p 9 -p 10 -p 11 -p 12 -T 1 -T 2 ], and pharmaceutically acceptable salts thereof, with P 1 to P 12 , T 1 and T 2 being elements as defined in the description and the claims, have Gram-negative antimicrobial activity to e.g. inhibit the growth or to kill microorganisms such as Klebsiella pneumoniae and/or Acinetobacter baumannii and/or Escherichia coli . They can be used as medicaments to treat or prevent infections or as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.

  一般式（I）的β-发夹肽类似物，其化学式为cyclo[P1-p2-p3-p4-p5-p6-p7-p8p9-p10-p11-p12-T1-T2]及其药用盐，其中P1至P12、T1和T2为描述和索赔中定义的元素，具有抗革兰氏阴性菌活性，例如抑制生长或杀灭肺炎克雷伯氏菌、鲍曼不动杆菌和/或大肠杆菌等微生物。它们可用作药物治疗或预防感染，或用作食品、化妆品、药物或其他营养物质的消毒剂。这些肽类似物可以通过基于混合固相和溶液相合成策略的工艺制造。
• TEMPLATE-FIXED PEPTIDOMIMETICS WITH CXCR7 MODULATING ACTIVITY
  申请人：Gombert Frank Otto

  公开号：US20130225506A1

  公开（公告）日：2013-08-29

  Novel template-fixed β-hairpin peptidomimetics of the general formula (I), wherein the single elements T or P are α-amino acid residues connected from the carbonyl (C═O) point of attachment to the nitrogen (N) of the next element in clockwise direction and wherein said elements, depending on their positions in the chain, are defined in the description and the claims have the property to act on the receptor CXCR7. Thus, these β-hairpin peptidomimetics can be useful in the treatment or prevention of diseases or conditions in the area of dermatological disorders, metabolic diseases, inflammatory diseases, fibrotic diseases, infectious diseases, neurological diseases, cardiovascular diseases, respiratory diseases, gastro-intestinal tract disorders, urological diseases, ophthalmic diseases, stomatological diseases, haematological diseases and cancer; or the mobilisation of stem cells.

  该模板固定的β-折叠肽类似物具有一般式（I），其中单个元素T或P是α-氨基酸残基，从羰基（C═O）连接点连接到顺时针方向下一个元素的氮（N），并且这些元素根据它们在链中的位置在说明书和权利要求中定义，具有作用于CXCR7受体的特性。因此，这些β-折叠肽类似物可用于治疗或预防皮肤疾病、代谢性疾病、炎症性疾病、纤维性疾病、感染性疾病、神经系统疾病、心血管疾病、呼吸系统疾病、胃肠道疾病、泌尿系统疾病、眼科疾病、口腔疾病、血液学疾病和癌症；或干细胞的动员。
• ECTOINE AND ECTOINE DERIVATIVES FOR USE IN VULVOVAGINAL CONDITIONS
  申请人：Laboratorios Litaphar, S.L.

  公开号：EP3498276A1

  公开（公告）日：2019-06-19

  The present invention relates to the use of the ectoine and ectoine derivatives for the treatment and/or prevention of a vulvovaginal dermatologic condition selected from the group consisting of vulvovaginal atrophy, lichen sclerosus and Zoon's vulvitis.

  本发明涉及将伊可新和伊可新衍生物用于治疗和/或预防外阴阴道皮肤病，这些皮肤病选自外阴阴道萎缩、苔藓样硬化症和祖恩氏外阴炎。
• ELEVATED RESISTANCE TO INSECTS AND PLANT PATHOGENS WITHOUT COMPROMISING SEED PRODUCTION
  申请人：Board of Trustees of Michigan State University

  公开号：EP3812464A1

  公开（公告）日：2021-04-28

  Described herein are modified plants, plant cells, and plant seeds that have at least one mutant loss-of-function JAZ gene and at least one loss-of-function cdk8 gene. Such plants are highly resistant to pests and environmental stress and have restored growth and increased seed yield compared to plant lines with a jazD genetic background.

  本文描述的是改良植物、植物细胞和植物种子，它们具有至少一个功能缺失的突变 JAZ 基因和至少一个功能缺失的 cdk8 基因。与具有 jazD 遗传背景的植物品系相比，这些植物对害虫和环境胁迫具有很强的抗性，并能恢复生长和提高种子产量。